Institut Pasteur Successfully Evaluates QIAGEN's Avian Flu/H5 Assay
QIAGEN N.V. announced that the Institut Pasteur in France successfully evaluated QIAGEN's artus® Influenza/H5 LC RT-PCR detection kit. The evaluation procedures of the Institut Pasteur included 18 different human influenza viruses, including 16 "seasonal" strains and two cases of human H5N1, and 12 avian strains covering 7 distinct sub-types (including recent H5N1). All these influenza viruses were correctly identified by QIAGEN's artus® Influenza/H5 LC RT-PCR detection kit. QIAGEN's sensitive assay allowed the detection of very low levels of less than 10 influenza viruses in the samples.
The artus® Influenza/H5 LC RT-PCR Kit is based on real-time PCR technology and combines a screening assay for all influenza A and B viruses with a highly specific detection of characteristic nucleic acids (RNA) of influenza A virus strains of subtype H5. QIAGEN's artus influenza detection products are for research use only. They have not been cleared or approved by regulatory authorities in the United States, or under the European IVD Directive, for human diagnostic or other clinical use, and are not intended and should not be used for human diagnostic or any other clinical purposes.
Most read news
Other news from the department research and development
These products might interest you

Vericheck ddPCR™ Empty-Full Capsid Kit by Bio-Rad Laboratories
Empty-to-Full Capsid Ratio Analysis For AAV-based Gene Therapy
Results within a day! Accurately measure protein & DNA simultaneously using ddPCR Technology

DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic World PCR
This groundbreaking and highly versatile molecular technique of PCR allows us to amplify tiny amounts of genetic material on a large scale and analyze them in detail. Whether in medical diagnostics, forensic DNA analysis or research into genetic diseases - PCR is an indispensable tool that gives us deep insights into the world of DNA. Immerse yourself in the fascinating world of the polymerase chain reaction (PCR)!

Topic World PCR
This groundbreaking and highly versatile molecular technique of PCR allows us to amplify tiny amounts of genetic material on a large scale and analyze them in detail. Whether in medical diagnostics, forensic DNA analysis or research into genetic diseases - PCR is an indispensable tool that gives us deep insights into the world of DNA. Immerse yourself in the fascinating world of the polymerase chain reaction (PCR)!
Last viewed contents
Tony_Wright_(sleep_deprivation)
Going live to the beating heart
Tianwang_buxin_mini-pills

Brain cell's Achilles' heel may prompt hydrocephalus
Biomass for biofuels, biochemicals will more than triple to 3.7 billion tons in 2030
List_of_eukaryotic_picoplankton_species
Epigenomics Signs Distribution Deal with Pronto Diagnostics for Epi proColon in Israel - Epigenomics expands commercial reach for CE-marked product beyond home market
The_Streets
Harrington_implant
Cerenis and Novasep awarded €10.7 million funding from the French Government for the development CER-001, an HDL mimetic
